Empatica Health Monitoring Platform

by Empatica S.R.L.  · Based in Italy →Our FDA-cleared health monitoring tools are designed to seamlessly collect and monitor health data from daily life.
Cardiology Neurology Sleep Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

Empatica Health Monitoring Platform is a comprehensive, full-stack digital health solution designed for continuous physiological monitoring and data analysis. Built on medical-grade wearable devices like EmbracePlus and EmbraceMini, it integrates a dedicated software suite (Care Lab App, Care Portal) and secure cloud infrastructure. The platform enables researchers, healthcare organizations, and clinical trial sponsors to collect and analyze a wide range of physiological signals, including electrodermal activity (EDA), heart rate (HR), heart rate variability (HRV), movement, skin temperature, blood oxygen saturation (SpO2), and respiratory rate. It provides access to both raw data and clinically validated digital biomarkers, supporting remote patient monitoring, decentralized clinical trials, and advanced clinical research across various therapeutic areas.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Medical-grade wearable devices (EmbracePlus, EmbraceMini)
  • Continuous physiological data collection (EDA, PPG, Accelerometer, Temperature, SpO2, Pulse Rate, Respiratory Rate)
  • Clinically validated digital biomarkers (300+ research-grade, 6 FDA-cleared)
  • Cloud-based data storage and management (Empatica Cloud, Care Portal)
  • Mobile app for data transfer (Care Lab App/Patient App)
  • Raw data access and export (CSV, Avro)
  • Remote study setup and management
  • Scalable for clinical trials and academic research
  • API for integration with existing systems (CTMS, EHR)
  • Long battery life (EmbracePlus up to 28 days)

Use Cases

  • Clinical Trials (decentralized, hybrid)
  • Academic Research
  • Remote Patient Monitoring
  • Parkinson's & Movement Disorders Monitoring
  • Epilepsy Monitoring (via EpiMonitor, part of the platform)
  • Actigraphy (sleep and physical activity)

What Physicians Need to Know

Evidence Base
The Empatica Health Monitoring Platform is built on scientific research, with its origins tracing back to MIT Media Lab in 2007, focusing on autonomic activity and seizure detection. It is utilized by major pharmaceutical companies for clinical trials and the development of novel digital biomarkers. The platform supports over 300 clinical and research-grade digital measures across numerous therapeutic areas, including ADHD, Alzheimer's, Anxiety, Autism, Circadian Rhythms, Depression, Diabetes, Epilepsy, Heart failure, Migraine, Parkinson's, PTSD, and Sleep Apnea. Empatica collaborates with partners like McRoberts, Mobilise-D, and PKG Health for algorithm development. The platform and its components are FDA-cleared and CE MDR certified.
Clinical Validation Studies
Empatica's devices, including EmbracePlus, EmbraceMini, and E4, are designed for clinical research and validated use cases. The EmbracePlus wristband's reflective pulse oximeter function demonstrated an accuracy root mean square (Arms) error of 2.4% in a controlled hypoxia study, which is within the FDA's 3.5% limit, and included participants with diverse skin pigmentation. The Empatica E4 wristband has been validated for measuring Heart Rate Variability (HRV) in research and clinical contexts, showing its ability to detect physiologically meaningful modulations of ANS activity. Empatica's Parkinson's Monitoring integrates PKG's clinically validated motor assessments with Empatica's wearable technology for tracking motor symptoms and therapy response. Empatica has also pioneered digital biomarker development, including the first FDA-cleared digital biomarker in neurology. The platform has been implemented in over 120 industry-sponsored trials. Empatica is also launching a study to develop an AI-based seizure forecasting algorithm using real-world data.
Alert Fatigue Management
For seizure detection, the Alert App automatically sends calls and SMS to designated caregivers when the Embrace device detects unusual patterns indicative of a convulsive seizure. While the algorithm has shown high specificity in clinical studies, false alarms can occur from daily activities. Users have a 15-second window to cancel a false alarm directly through the app or by tapping the watch face twice. Empatica provides guidance to reduce false alarms, such as ensuring proper device fit and wearing it on the non-dominant wrist.
Clinical Workflow Integration
The Empatica Health Monitoring Platform is designed for seamless integration into existing clinical trial management systems (CTMS) and Contract Research Organization (CRO) workflows through its Cloud APIs. It facilitates automated data transfer to streamline study setup and analysis. The Care Portal enables remote study setup and management, participant oversight, and visualization of digital biomarkers. The user-friendly Care App integrates eCOA modules (ePRO, ePerfO, medication reminders) to provide a unified patient experience, thereby reducing patient and site burden. Data is securely stored in the Empatica Cloud and is accessible for download in Avro and CSV formats. The platform supports continuous, long-term monitoring, allowing healthcare professionals to analyze symptom trends and physiological patterns over extended periods.
Decision Audit Trail
The Empatica Health Monitoring Platform provides regulatory support and audit trails for clinical trials, indicating that data access and modifications are logged for compliance purposes.
Physician Tip

Leverage the continuous, real-world physiological data and validated digital biomarkers from Empatica to gain deeper insights into patient conditions and treatment responses, particularly for chronic neurological disorders like epilepsy and Parkinson's. Utilize the platform's robust integration capabilities to streamline data flow into existing clinical management systems, reducing manual data entry and improving efficiency. Educate patients on proper device wearing and false alarm management for seizure detection to ensure data accuracy and minimize unnecessary caregiver alerts. Focus on the objective measures provided by Empatica to complement subjective patient reports, leading to more informed and personalized treatment decisions.

The Empatica Health Monitoring Platform offers robust Cloud APIs for seamless integration with existing clinical trial management systems (CTMS) and CRO workflows. It facilitates data transfer to preferred systems and provides data in Avro and CSV formats for compatibility with various analytical tools. The Care App also integrates eCOA modules (ePRO, ePerfO, medication reminders) for a unified patient data collection experience, minimizing patient burden and streamlining data capture.

Details

Category Clinical Decision Support & Reference, Drug Discovery & Research, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
  • Contact for platform pricing; Academic research bundles available (e.g., 1 EmbracePlus + 3 years data/portal access for $1749.60 with discount, or 5 years for $2187 with discount)
  • EpiMonitor (for epilepsy) has a $399 one-time device fee with monthly subscriptions starting at $15.90
DeploymentCloud-based with companion mobile application and wearable devices.
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

The Empatica Health Monitoring Platform received initial FDA clearance in November 2022 for continuous data collection to monitor SpO2, electrodermal activity, skin temperature, and movement during sleep. In November 2023, it received additional 510(k) clearance for digital biomarkers measuring pulse and respiratory rate, expanding its FDA-cleared physiological measures to six. The K242737 is associated with the Empatica Health Monitoring Platform, EmbracePlus, Empatica Care, and Care Portal.

Integrations
EHR Not specified
Specialties Cardiology, Neurology, Sleep Medicine

What the Web Says

The Empatica Health Monitoring Platform is a comprehensive solution for remote health data collection and monitoring, particularly noted for its FDA clearance for continuous data collection of various physiological parameters. It is widely used in clinical trials and academic research for developing digital biomarkers and monitoring conditions like epilepsy and Parkinson's disease. The platform combines wearable devices (EmbracePlus and EmbraceMini) with a software suite and cloud infrastructure for data management and analysis.

Overall: Mixed

Strengths

  • FDA-cleared for continuous data collection of multiple physiological parameters (Electrodermal Activity, skin temperature, SpO2, movement during sleep, pulse and respiratory rate).
  • Provides high-quality raw sensor data and clinically validated digital biomarkers.
  • Scalable for large-scale clinical trials and academic research across multiple participants and locations.
  • User-friendly wearable devices (EmbracePlus and EmbraceMini) designed for comfort and ease of use.
  • Supports remote patient monitoring and decentralized clinical trials, reducing the burden on healthcare facilities.
  • Offers multi-language support for global trial operations and diverse data collection.

Limitations

  • Some users report issues with false alerts, particularly with seizure detection, leading to a loss of confidence in the product.
  • Concerns about the pricing model, including monthly subscription fees for essential features like caregiver notifications and access to seizure reports, which some find excessive.
  • The mobile app (Empatica Care) has been criticized for significant battery drain and occasional connectivity issues (Bluetooth and internet).
  • Customer service has been described as slow and unhelpful by some users.
  • Limited customization options for the wearable device's user interface, posing challenges for individuals with low vision or color contrast issues.
  • The requirement for a phone to be in close Bluetooth proximity for data transmission can be a drawback for continuous monitoring, especially for children or individuals with cognitive deficits.

Based on reviews from: Empatica's 2022 in review, Empatica Health Monitoring Platform, Empatica Health Monitoring Platform | For Research Studies, Empatica | Medical devices, AI and algorithms for remote patient monitoring, Empatica Care - App Store, Empatica Health Monitoring Platform for Clinical Trials, Empatica - Wikipedia, Testimonials | Embrace Reviews | Seizure Detection - Empatica, Empatica epilepsy watch rip-off - Reddit, Seizure monitoring watch for safety (Empatica) : r/Epilepsy - Reddit, Empatica Health Monitoring Platform | Remote Patient Monitoring, Empatica Epimonitor Watch : r/Epilepsy - Reddit, Empatica Epimonitor : r/Epilepsy - Reddit, Empatica watch : r/Epilepsy - Reddit, EmbracePlus | The world's most advanced smartwatch for continuous health monitoring, Empatica EpiMonitor Experiences? Also looking for nighttime spO2 Monitoring device suggestions as well! : r/Epilepsy - Reddit, Read Customer Service Reviews of www.empatica.com - Trustpilot, u/Empatica - Reddit, The Empatica Health Monitoring Platform receives FDA-clearance, How the Empatica Health Monitoring Platform can enhance your research studies, EpiMonitor by Empatica - Ratings & Reviews - App Store - Apple, FDA Clears Empatica's EmbraceMini for Sleep Monitoring, Understanding your Empatica Health Monitoring Platform Plan, 2025: Empatica's year in review, EmpMonitor Reviews 2026: Details, Pricing, & Features - G2, Empatica Care - Apps on Google Play, Capterra Reviews 2026: Details, Pricing, & Features | G2, OptiMantra Reviews 2026. Verified Reviews, Pros & Cons | Capterra, TheraPlatform Reviews 2026. Verified Reviews, Pros & Cons | Capterra

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Empatica Health Monitoring Platform

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Empatica
Empatica Receives New FDA Clearance for Cardiac Digital Biomarkers
Empatica announced FDA 510(k) clearance for pulse and respiratory rate digital biomarkers, expanding its Health Monitoring Platform to include six FDA-cleared biomarkers for clinical trials.
2023-11
Empatica
The Empatica Health Monitoring Platform receives FDA-clearance
Empatica's Health Monitoring Platform received initial FDA clearance in November 2022 for continuous data collection to monitor Electrodermal Activity, SpO2, skin temperature, and movement during sleep.
2022-11
Empatica
Empatica Receives European MDR Certification for Health Monitoring Platform
Empatica's Health Monitoring Platform received CE Mark Certification under the European Union's Medical Device Regulation (MDR), making it a solution with both CE MDR certification and FDA clearance.
2024-12
Empatica
FDA Clears Empatica's EmbraceMini for Sleep Monitoring
Empatica announced FDA 510(k) clearance for EmbraceMini, a medical-grade wearable for remote health monitoring, enabling high-quality sleep and circadian rhythm assessments.
2026-01
Empatica
Empatica Acquires PKG Health to Transform Parkinson's Disease Monitoring
Empatica acquired PKG Health, integrating its validated algorithms for movement disorder monitoring into Empatica's platform to enhance Parkinson's disease monitoring.
2025-10
Empatica
Empatica receives landmark FDA PCCP authorization for pulse oximetry
Empatica received FDA authorization for its pulse oximetry (SpO2) algorithm with a Predetermined Change Control Plan (PCCP), allowing for algorithm updates without new 510(k) submissions.
2025-06
Business Wire
Empatica Unveils EmbraceMini: The World's Smallest Actigraphy Wearable for Clinical Trials
Empatica unveiled EmbraceMini, an ultra-compact wearable for clinical trials designed for seamless and non-invasive activity data collection, wirelessly transmitting data to the FDA-cleared Empatica Health Monitoring Platform.
2025-06
PMC (Peer-Reviewed Medical Journal)
Validity of Empatica E4 Wristband for Detection of Autonomic Dysfunction Compared to Established Laboratory Testing
A study published in PMC concluded that the Empatica E4 wristband is valid for measuring heart rate variability (HRV) in research and clinical contexts, detecting physiologically meaningful modulations of autonomic nervous system activity.
2025-10

Videos

Product demos, reviews, and walkthroughs for Empatica Health Monitoring Platform.

View all on YouTube

Frequently Asked Questions

The Empatica Health Monitoring Platform leverages AI-enabled tools for forecasting, monitoring, research, and treatment. It collects physiological data from wearable devices like EmbracePlus and EmbraceMini, processing it into clinically validated digital biomarkers. Physicians can access and visualize real-time vitals and trends through the Care Portal, which aids in data-driven decision-making and supports early intervention.
The Empatica Health Monitoring Platform has received FDA clearance in the United States and CE Mark certification under the European Union's Medical Device Regulation (MDR 2017/745). These certifications demonstrate compliance with stringent medical device standards, and the platform also adheres to GDPR and HIPAA for data protection and privacy.
Empatica's digital biomarkers are derived from algorithms trained and validated against gold standards in clinical studies. While heart rate variability (HRV) measurements from Empatica devices have shown robust reliability, studies indicate that the accuracy of other signals, such as electrodermal activity and skin temperature, may have limitations when compared to established laboratory methods.
Yes, the Empatica Health Monitoring Platform is designed for integration into existing healthcare infrastructure. It offers a plug-and-play SDK that allows medical-grade data from EmbracePlus to be incorporated into EHRs and other clinical systems. This enables healthcare providers to access both raw physiological data and digital biomarkers directly within their established workflows.
Key competitors in the digital health monitoring space include companies like Sentinel, MC10, Koneksa Health, Evidation Health, and ActiGraph. Empatica differentiates itself through its comprehensive FDA-cleared and CE MDR certified platform, offering over 300 digital measures from medical-grade wearables like EmbracePlus and EmbraceMini for continuous, remote patient monitoring.
While specific enterprise pricing for large healthcare organizations is not publicly detailed, Empatica offers various subscription plans for products like EpiMonitor (Basic, Standard, Plus with monthly or annual options). Bundles for the EmbracePlus device include 3 or 5 years of data access via the Empatica Cloud and Care Portal access for study management and data visualization. Academic discounts are also available.
Limitations for specific devices, such as the Embrace2, include not predicting seizure onset and not being intended for use during physical activity or as a stand-alone monitoring device. While the platform is FDA-cleared for various physiological parameters, the accuracy of certain wearable-derived signals like electrodermal activity and temperature can be less reliable compared to gold-standard laboratory measurements.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

More from Empatica S.R.L.

Care Portal
Empatica S.R.L.
Clinical Decision Support & Reference
Care Portal is a web-based component of the Empatica Health Monitoring Platform, designed for professionals to manage and monitor participants in various care settings and research studies. It integrates data collected from Empatica’s medical-grade wearables, such as EmbracePlus and EmbraceMini, which continuously measure physiological parameters like heart rate, electrodermal activity, motion, and skin temperature. What […]
EmbracePlus
Empatica S.R.L.
Drug Discovery & Research
EmbracePlus by Empatica is an FDA-cleared medical-grade wearable device and platform for continuous physiological monitoring, digital biomarker development, and remote data collection in clinical trials and academic research.
Empatica Care
Empatica S.R.L.
Clinical Decision Support & Reference
Empatica Care is part of the Empatica Health Monitoring Platform, utilizing medical-grade wearables to collect continuous physiological data for remote patient monitoring and clinical research, accessible via a mobile app and web portal.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.